BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9835455)

  • 1. Is the capacity for lymph node-mediated distant dissemination the same for all nodal groups in malignant melanoma?
    Karakousis CP; Balch CM; Bartolucci A; Driscoll DL
    Melanoma Res; 1998 Oct; 8(5):419-24. PubMed ID: 9835455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
    Lee RJ; Gibbs JF; Proulx GM; Kollmorgen DR; Jia C; Kraybill WG
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):467-74. PubMed ID: 10661355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis.
    Coit DG; Rogatko A; Brennan MF
    Ann Surg; 1991 Nov; 214(5):627-36. PubMed ID: 1953117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of preoperative lymphoscintigraphy in surgery planning for sentinel lymph node biopsy in malignant melanoma.
    Vucetić B; Andreja Rogan S; Balenović A; Ivkić M; Situm M; Hudorović N; Kusić Z
    Wien Klin Wochenschr; 2006 May; 118(9-10):286-93. PubMed ID: 16810487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant irradiation for axillary metastases from malignant melanoma.
    Ballo MT; Strom EA; Zagars GK; Bedikian AY; Prieto VG; Mansfield PF; Lee JE; Gershenwald JE; Ross MI
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):964-72. PubMed ID: 11958890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasis.
    Glover AR; Allan CP; Wilkinson MJ; Strauss DC; Thomas JM; Hayes AJ
    Br J Surg; 2014 Jun; 101(7):811-9. PubMed ID: 24752717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous lymphatic drainage in patients with grossly involved nodal basins.
    Kamath D; Brobeil A; Stall A; Lyman G; Cruse CW; Glass F; Fenske N; Messina J; Berman C; Reintgen D
    Ann Surg Oncol; 1999 Jun; 6(4):345-9. PubMed ID: 10379854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of morbidity following regional nodal dissection in the axilla and groin for metastatic melanoma.
    Theodore JE; Frankel AJ; Thomas JM; Barbour AP; Bayley GJ; Allan CP; Wagels M; Smithers BM
    ANZ J Surg; 2017 Jan; 87(1-2):44-48. PubMed ID: 27102082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin.
    Allan CP; Hayes AJ; Thomas JM
    ANZ J Surg; 2008 Nov; 78(11):982-6. PubMed ID: 18959697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete lymph node dissection for regional nodal metastasis.
    Dzwierzynski WW
    Clin Plast Surg; 2010 Jan; 37(1):113-25. PubMed ID: 19914463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How often do level III nodes bear melanoma metastases and does it affect patient outcomes?
    Nessim C; Law C; McConnell Y; Shachar S; McKinnon G; Wright F
    Ann Surg Oncol; 2013 Jun; 20(6):2056-64. PubMed ID: 23370671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin.
    Melstrom LG; Taylor E; Kuk D; Frankel TL; Panageas K; Haydu L; Sabel MS; Thompson JF; Ariyan C; Coit DG; Brady MS
    Ann Surg Oncol; 2014 Dec; 21(13):4324-9. PubMed ID: 24962937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decades.
    Esmaeli B; Wang X; Youssef A; Gershenwald JE
    Ophthalmology; 2001 Nov; 108(11):2101-5. PubMed ID: 11713086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasonographic detection of regional lymph node metastases in patients with intermediate or thick malignant melanoma.
    Brountzos EN; Panagiotou IE; Bafaloukos DI; Kelekis DA
    Oncol Rep; 2003; 10(2):505-10. PubMed ID: 12579298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node biopsy does not impair survival after therapeutic dissection for palpable melanoma metastases.
    Kelemen PR; Wanek LA; Morton DL
    Ann Surg Oncol; 1999 Mar; 6(2):139-43. PubMed ID: 10082037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined clearance of pelvic and superficial nodes for clinical groin melanoma.
    West CA; Saleh DB; Peach H
    J Plast Reconstr Aesthet Surg; 2014 Dec; 67(12):1711-8. PubMed ID: 25219338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of an iliac/obturator lymph node dissection does not improve nodal recurrence or survival in melanoma.
    Egger ME; Brown RE; Roach BA; Quillo AR; Martin RC; Scoggins CR; Stromberg AJ; McMasters KM
    J Am Coll Surg; 2014 Jul; 219(1):101-8. PubMed ID: 24726566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma probe-directed lymphatic mapping and sentinel lymphadenectomy in primary melanoma: Reliability of the procedure and analysis of failures after long-term follow-up.
    Jacobs IA; Chevinsky AH; Swayne LC; Magidson JG; Britto EJ; Smith TJ
    J Surg Oncol; 2001 Jul; 77(3):157-64. PubMed ID: 11455551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.
    Gershenwald JE; Colome MI; Lee JE; Mansfield PF; Tseng C; Lee JJ; Balch CM; Ross MI
    J Clin Oncol; 1998 Jun; 16(6):2253-60. PubMed ID: 9626228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.